Article info
PDFHepatology
Original research
Long-term safety of infants from mothers with chronic hepatitis B treated with tenofovir disoproxil in China
- Correspondence to Professor Calvin Q. Pan, Center of Liver Diseases, Beijing Ditan Hospital, Capital Medical University, Beijing, China; Panc01{at}NYU.edu
Citation
Long-term safety of infants from mothers with chronic hepatitis B treated with tenofovir disoproxil in China
Publication history
- Received August 3, 2020
- Revised March 4, 2021
- Accepted March 15, 2021
- First published March 31, 2021.
Online issue publication
May 18, 2022
Article Versions
- Previous version (7 March 2022).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ.